Search Results

You are looking at 41 - 50 of 96 items for :

  • "skin cancer" x
Clear All
Full access

. New NCCN Imaging AUC have been published for: Basal Cell Skin Cancer Bone Cancer Breast Cancer Screening and Diagnosis Central Nervous System Cancers Cervical Cancer Colorectal Cancer Screening Dermatofibrosarcoma Protuberans Kidney

Full access

John A. Thompson

Research on Cancer Working Group on Artificial Ultraviolet (UV) Light and Skin Cancer . The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review . Int J Cancer 2007 ; 120 : 1116 – 1122 . 4

Full access

recommendations for each stage of melanoma skin cancer. This update includes important changes to the recommended systemic therapy options for advanced or metastatic melanoma. These options are now divided into “preferred” and “other” regimens. Also, imatinib

Full access

Grant A. McArthur

Basal Cell and Squamous Cell Skin Cancers Guidelines, version 1 , 2007 . Available at : http://www.nccn.org/professionals/physician_gls/default.asp . Accessed April 9, 2007 . 24. Garcia C Holman J Poletti E . Mohs surgery: commentaries

Full access

-Melanoma Skin Cancer Non–Small Cell Lung Cancer Prostate Cancer T-Cell and Primary Cutaneous Lymphomas Screening and Early Detection Prostate Cancer Supportive Care Hematopoietic Growth Factors Infectious Disease Management Managing Isolation Self-Care and

Full access

Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, Murad Alam, James S. Andersen, Rachel Blitzblau, Glen M. Bowen, Carlo M. Contreras, Gregory A. Daniels, Roy Decker, Jeffrey M. Farma, Kris Fisher, Brian Gastman, Karthik Ghosh, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Manisha Loss, Daniel D. Lydiatt, Jane Messina, Kishwer S. Nehal, Paul Nghiem, Igor Puzanov, Chrysalyne D. Schmults, Ashok R. Shaha, Valencia Thomas, Yaohui G. Xu, John A. Zic, Karin G. Hoffmann and Anita M. Engh

Merkel cell carcinoma (MCC) is a cutaneous neuroendocrine neoplasia formerly called trabecular carcinoma . Although rare, with approximately 2,488 cases per year diagnosed in the United States, 1 MCC is one of the most aggressive skin cancers, and its

Full access

, Version 2.2016 Basal Cell Skin Cancer, Version 1.2017 Dermatofibrosarcoma Protuberans, Version 1.2017 Gastric Cancer, Version 1.2017 Hodgkin Lymphoma, Version 1.2017 Merkel Cell Carcinoma, Version 1.2017 Ovarian Cancer, Version 1

Full access

Suneel D. Kamath, Sheetal M. Kircher and Al B. Benson III

(smoking), head and neck (smoking, alcohol), bladder (smoking), esophageal (smoking, alcohol), liver (alcohol, intravenous drug use), cervical (sex), and nonmelanoma skin cancers (tanning beds). 11 – 15 All 7 were poorly funded in at least one

Full access

Christopher K. Bichakjian, Thomas Olencki, Murad Alam, James S. Andersen, Daniel Berg, Glen M. Bowen, Richard T. Cheney, Gregory A. Daniels, L. Frank Glass, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Daniel D. Lydiatt, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Clifford S. Perlis, Ashok R. Shaha, Wade L. Thorstad, Malika Tuli, Marshall M. Urist, Timothy S. Wang, Andrew E. Werchniak, Sandra L. Wong, John A. Zic, Nicole McMillian, Karin Hoffman and Maria Ho

treatment of nonmelanoma skin cancers. The NCCN Guidelines for DFSP are an extension of these guidelines that provide specific recommendations for DFSP management. The panel also received expert input from the NCCN Guidelines Panel for Soft Tissue Sarcoma

Full access

Tanner M. Johanns, George Ansstas and Sonika Dahiya

in secondary skin cancers, possibility of reduced resistance, and longer duration of response 26 would favor the use of dual BRAFi/MEKi over single-agent regimens regardless of response rate. In addition to defining the efficacy of BRAF